Sangamo Therapeutics (SGMOQ) Other Working Capital Changes (2017 - 2025)

Sangamo Therapeutics has reported Other Working Capital Changes for 16 years, with the latest figure at -$448000.0 in Q4 2025.

• On a quarterly basis, Other Working Capital Changes fell 295.63% year-over-year to -$448000.0 in Q4 2025; TTM through Dec 2025 was -$4.0 million, a 27.46% increase from a year earlier, with the FY2025 full-year figure at -$4.0 million, up 27.46% from the prior year.
• Other Working Capital Changes was -$448000.0 for Q4 2025 at Sangamo Therapeutics, up from -$1.3 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $12.7 million in Q4 2024, with the low at -$149.8 million in Q1 2023.
• Average Other Working Capital Changes over 5 years is -$22.0 million, with a median of -$20.8 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2024: Other Working Capital Changes jumped 894.08% in 2021, then slumped 867.61% in 2024.
• Over 5 years, Other Working Capital Changes stood at $708000.0 in 2021, then slumped by 232.63% to -$939000.0 in 2022, then slumped by 442.81% to -$5.1 million in 2023, then jumped by 104.49% to $229000.0 in 2024, then tumbled by 295.63% to -$448000.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$448000.0 (Q4 2025), -$1.3 million (Q3 2025), and -$4.9 million (Q2 2025), per Business Quant data.